Showing results (31-40 of 41) with videos related to
Sort By:
Pageof 5
Scientific Reports|October 6, 2021
Enhancing adoptive CD8 T cell therapy by systemic delivery of tumor associated antigensDitte E Jæhger, Mie L Hübbe, Martin K Kræmer, et al.Communications Biology|July 2, 2021
Optical tissue clearing and machine learning can precisely characterize extravasation and blood vessel architecture in brain tumorsSerhii Kostrikov, Kasper B Johnsen, Thomas H Braunstein, et al.Advanced Healthcare Materials|March 25, 2021
Effective Intratumoral Retention of [103 Pd]AuPd Alloy Nanoparticles Embedded in Gel-Forming Liquids Paves the Way for New NanobrachytherapyMatthias Fach, Frederikke P Fliedner, Paul J Kempen, et al.ACS Nano|October 30, 2018
Theranostic Imaging May Vaccinate against the Therapeutic Benefit of Long Circulating PEGylated Liposomes and Change Cargo PharmacokineticsBetina Børresen, Jonas R Henriksen, Gael Clergeaud, et al.Journal of Immunology (Baltimore, Md. : 1950)|April 30, 2025
Micellar formulation provides potent and tolerable TLR7 agonist treatment for anti-cancer immunotherapyEsben Christensen, Camilla Stavnsbjerg, Rasmus Münter, et al.RSC Medicinal Chemistry|August 16, 2024
Chemical synthesis and immunological evaluation of cancer vaccines based on ganglioside antigens and α-galactosylceramideCecilia Romanò, Hao Jiang, Sahar Tahvili, et al.American Journal of Nuclear Medicine and Molecular Imaging|January 28, 2015
Simultaneous hyperpolarized (13)C-pyruvate MRI and (18)F-FDG-PET in cancer (hyperPET): feasibility of a new imaging concept using a clinical PET/MRI scannerHenrik Gutte, Adam E Hansen, Sarah T Henriksen, et al.Biomacromolecules|July 16, 2026
Nanodisc-Forming Polymers as TLR7/8 Agonist-Conjugated Immunotherapy AgentsNeil J Borthwick, Ciara F Pugh, Kristoffer H Johansen, et al.Advanced Healthcare Materials|January 22, 2015
Injectable Colloidal Gold for Use in Intrafractional 2D Image-Guided Radiation TherapyRasmus I Jølck, Jonas S Rydhög, Anders N Christensen, et al.Nature Communications|September 3, 2024
An in situ depot for the sustained release of a TLR7/8 agonist in combination with a TGFβ inhibitor promotes anti-tumor immune responsesSophie B Jensen, Ditte E Jæhger, Elizabeth Serrano-Chávez, et al.Pageof 5